A detailed history of High Point Advisor Group LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, High Point Advisor Group LLC holds 12,524 shares of EW stock, worth $820,071. This represents 0.07% of its overall portfolio holdings.

Number of Shares
12,524
Previous 12,515 0.07%
Holding current value
$820,071
Previous $1.2 Million 3.26%
% of portfolio
0.07%
Previous 0.09%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $758 - $848
9 Added 0.07%
12,524 $1.16 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $797 - $1,051
-11 Reduced 0.09%
12,515 $1.2 Million
Q4 2023

Mar 26, 2024

SELL
$61.71 - $77.76 $616,791 - $777,211
-9,995 Reduced 44.38%
12,526 $955,000
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $986,792 - $1.46 Million
11,408 Added 102.65%
22,521 $2.21 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $19,861 - $23,690
-193 Reduced 1.71%
11,113 $1.26 Million
Q2 2021

Jul 29, 2021

BUY
$83.84 - $104.76 $56,508 - $70,608
674 Added 6.34%
11,306 $1.17 Million
Q1 2021

Apr 12, 2021

BUY
$78.68 - $90.67 $130,923 - $150,874
1,664 Added 18.55%
10,632 $914,000
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $50,398 - $64,134
703 Added 8.51%
8,968 $769,000
Q3 2020

Nov 06, 2020

SELL
$67.19 - $87.44 $32,587 - $42,408
-485 Reduced 5.54%
8,265 $641,000
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $338,910 - $453,235
5,890 Added 205.94%
8,750 $604,000
Q1 2020

May 01, 2020

BUY
$52.41 - $81.0 $116,402 - $179,901
2,221 Added 347.57%
2,860 $639,000
Q1 2020

Apr 27, 2020

SELL
$52.41 - $81.0 $242,815 - $375,273
-4,633 Reduced 87.88%
639 $2.86 Million
Q4 2019

Feb 13, 2020

SELL
$71.7 - $82.09 $7,385 - $8,455
-103 Reduced 1.92%
5,272 $1.28 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $153,197 - $187,745
2,489 Added 86.24%
5,375 $1.26 Million
Q2 2019

Aug 15, 2019

SELL
$55.74 - $64.41 $1,337 - $1,545
-24 Reduced 0.82%
2,886 $559,000
Q1 2019

May 08, 2019

SELL
$47.89 - $64.05 $143 - $192
-3 Reduced 0.1%
2,910 $518,000
Q4 2018

Feb 20, 2019

BUY
$46.41 - $56.94 $4,084 - $5,010
88 Added 3.12%
2,913 $515,000
Q3 2018

Oct 24, 2018

SELL
$45.7 - $58.03 $3,701 - $4,700
-81 Reduced 2.79%
2,825 $422,000
Q2 2018

Aug 20, 2018

BUY
$42.45 - $51.3 $382 - $461
9 Added 0.31%
2,906 $405,000
Q1 2018

Jun 11, 2018

BUY
$37.19 - $47.45 $29,677 - $37,865
798 Added 38.02%
2,897 $414,000
Q4 2017

Feb 15, 2018

SELL
$33.79 - $39.39 $10,204 - $11,895
-302 Reduced 12.58%
2,099 $267,000
Q3 2017

Nov 06, 2017

BUY
$36.29 - $38.83 $87,132 - $93,230
2,401
2,401 $243,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.